 |
Trials |
A Phase II Randomized, Double-blind, Placebo-controlled Trial of Radium-223 Dichloride Versus Placebo When Administered to Metastatic HER2 Negative Hormone Receptor Positive Breast Cancer Subjects With Bone Metastases Treated With Hormonal Treatment BackgCancer type: Breast cancer Phase: II Principal Investigator: Danø Hella Country: DK Keywords: Denmark, Herlev, breast cancer Status: Completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02258464?term=02258464&rank=1 |